Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| PTGX (Protagonist Therapeutics, Inc.) | 25.70% | 98.39% | 55.89% | 22.60% | NA | NA | NA | … | … |
Data as of 06/11/2026, Common starting date is 08/11/2016
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| PTGX (Protagonist Therapeutics, Inc.) | 08/11/2016 | 06/11/2026 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | 6.81 | 98.39 | 55.89 | 22.60 | NA | NA | NA | … | … | 25.70 | 130.00 | 69.91 | 110.17 | -68.10 | 69.64 | 185.96 | 4.75 | -67.64 | -5.41 | 87.95 |
| Sharpe Ratio | NA | 1.61 | 0.88 | 0.23 | NA | NA | NA | … | … | 0.62 | 2.10 | 1.28 | 1.53 | -0.70 | 0.52 | 1.91 | -0.17 | -0.75 | -0.35 | 6.47 |
| Standard Deviation(%) | NA | 48.67 | 53.34 | 87.75 | NA | NA | NA | … | … | 42.51 | 61.96 | 50.16 | 70.15 | 99.10 | 135.01 | 96.65 | 107.04 | 118.43 | 70.96 | 57.80 |
| Draw Down(%) | NA | 16.38 | 52.15 | 85.79 | NA | NA | NA | … | … | 12.03 | 31.58 | 23.30 | 52.15 | 80.43 | 73.94 | 41.43 | 71.68 | 74.05 | 62.62 | 23.44 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | … | … | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data as of 06/11/2026, Common starting date is 08/11/2016
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| PTGX (Protagonist Therapeutics, Inc.) |
-31.56%
Dec 2016 – Dec 2019 |
-16.51%
Nov 2017 – Nov 2022 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| PTGX (Protagonist Therapeutics, Inc.) |
124.92%
Nov 2022 – Nov 2025 |
46.94%
Mar 2020 – Mar 2025 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison Chart